Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1.42M
-
Shares change
-
-72.2K
-
Total reported value, excl. options
-
$693K
-
Value change
-
-$52.4K
-
Number of buys
-
1
-
Number of sells
-
-6
-
Price
-
$0.49
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2020
18 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2020.
IGC Pharma, Inc. - COM NEW (IGC) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.42M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (454K shares), GEODE CAPITAL MANAGEMENT, LLC (262K shares), Carroll Financial Associates, Inc. (215K shares), DEARBORN PARTNERS LLC (103K shares), BlackRock Inc. (94.5K shares), NORTHERN TRUST CORP (93.6K shares), GOLDMAN SACHS GROUP INC (66.3K shares), BANK OF MONTREAL /CAN/ (45K shares), Sowell Financial Services LLC (37.3K shares), and TRUIST FINANCIAL CORP (36.7K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.